Seeking Alpha

Seeking Alpha Portfolio App for iPad

1,805 people get ILMN articles and Market Currents by email alert.

Get email alerts on ILMN »

ILMN

Illumina, Inc.

5/25/2013, 4:47 AM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 15, 6:03 PM Third Point discloses new positions in: Anadarko Petroleum (APC), BE Aerospace (BEAV), Cabot Oil (COG), Chimera Investment (CIM), Hess (HES), Hilshire Brands (HSH), Tiffany (TIF), Thermo Fisher (TMO), and Virgin Media (MMED). It raises stakes in: AbbVie (ABBV) and International Paper (IP), and exits Abbott Labs (ABT), Capital One (COF), Coca-Cola Enterprises (CCE), Herbalife (HLF), Illumina (ILMN), MetLife (MET), Morgan Stanley (MS) and Tesoro (TSO). (13-F) 4 Comments
Friday, May 10, 3:29 PM Shares of Illumina (ILMN +10%) ramp higher today, spiking up on heavy volume with no apparent news driving the move. Of note; short interest in the stock continues to inch higher, but days to cover has plummeted as average daily volume in the shares has nearly doubled since March, bringing it back to nearly 2M shares per day, a level it hasn't seen since January - and perhaps an indication of piquing institutional interest. Comment! [Healthcare, On the Move]
Tuesday, April 23, 12:56 PM Midday top 10 gainers: SCON +118%. MEMS +49%. CZR +29%. NFLX +24%. ARL +18%. CPLA +18%. VECO +17%. HSTM +17%. SANM +16%. ILMN +15%.
Midday top 10 losers: CPRX -15%. IIVI -13%. UNTK -13%. ABIO -13%. CASM -10%. EFUT -9%. GASS -9%. TAX -8%. SIFY -7%. USTR -7%. Comment! [On the Move]
Tuesday, April 23, 9:27 AM Illumina (ILMN) moves higher in pre-trading after easily beating on its Q1 yesterday. In its conference call, the company reiterates that it expects a 2% - 4% impact as a result of sequestration, suggesting the damage will likely be limited. One of the offsetting factors management mentions is that "under the continuing resolution much of the NIH allocation was at 90% of the grant amount and so that has a potential small upside effect that could neutralize any of the downside effects from sequestration." Read more on the call here: (Earnings Call Transcript). Shares +9.3% pre-open. Comment! [Healthcare, Earnings, On the Move]
Tuesday, April 23, 9:10 AM Premarket gainers: MEMS +50%. SCON +46%. NFLX +24%. VECO +14%. COH +12%. ILMN +10%. ARMH +9%. CZR +8%. STM +6%. AMRN +6%.
Losers: IRWD -10%. RSH -7%. IOC -6%. Comment! [On the Move]
Monday, April 22, 5:54 PM After-hours top gainers, as of 5:15 p.m.: VECO +9%. SWFT +6%. ILMN +4%. WIT +4%. QCCO +3%.
After-hours top losers: BEAT -11%. RCII -6%. HOV -5%. RFMD -5%. REGI -4%. 1 Comment [On the Move]
Monday, April 22, 5:10 PM More on Illumina (ILMN): The stock is trading higher in the post session as its Q1 easily beats across the board on a 21% jump in revenue Y/Y. The company swung to a net loss for the quarter however, after taking nearly a $107M loss related to its unfavorable verdict in its patent litigation with Syntrix Biosystems. R&D and SG&A expenses were both higher as a percentage of revenue, while margins were relatively flat compared to the prior year. Shares +4.3% AH. Comment! [Earnings, On the Move]
Monday, April 22, 4:20 PM Illumina (ILMN): Q1 EPS of $0.46 beats by $0.07. Revenue of $331M beats by $20.36M. Shares +4.3% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
Monday, April 22, 12:10 AM Notable earnings after Monday’s close: ACE, AMP, CNI, HXL, ILMN, NFLX, NXPI, PKG, RCI, SANM, STM, SWFT, TXN, VECO, ZION Comment! [Earnings]
Sunday, April 21, 5:35 PM Notable earnings after Monday’s close: ACE, AMP, CNI, HXL, ILMN, NFLX, NXPI, PKG, RCI, SANM, STM, SWFT, TXN, VECO, ZION Comment! [Earnings]
Thursday, April 18, 7:52 AM Illumina (ILMN) says its TruSight content sets and Infinium assays will be adopted by Kindstar Global across a network of 3,300 hospitals in China. Separately, SA contributor PropThink says Thermo Fisher's "willingness to pay up for Life Technologies" may reignite talks between ILMN and longtime suitor Roche, as the deal shows "premiums in this expanding segment of healthcare aren't unheard of." Comment! [Healthcare]
Thursday, March 28, 4:33 PM Halozyme Therapeutics (HALO) says it's appointed Matt Posard to its Board of Directors. Mr. Posard is currently SVP and General Manager of Translational & Consumer Genomics at Illumina (ILMN). Shares +0.2% AH Comment! [Healthcare]
Thursday, March 21, 4:33 PM Illumina (ILMN) wins a favorable judgment in its patent litigation against Life Technologies (LIFE), with the court saying that its sequencing systems do not infringe on LIFE's patents. Life Technologies filed the lawsuit against ILMN in 2009. The Court ruled that, “Life Tech cannot establish, as a matter of law, that the accused Illumina systems infringe” the patents. ILMN +1.4% AH. Comment! [Healthcare, On the Move]
Monday, January 28, 4:31 PM More on Illumina (ILMN): Q4 beats on the top line as total sales jump 24% Y/Y. The company also guides FY13 earnings lower, now expecting to see its EPS in the range of $1.55 - $1.62, below ccurrent Street estimates of $1.73. Comment! [Healthcare, Earnings]
Monday, January 28, 4:10 PM Illumina (ILMN): Q4 EPS of $0.42 in-line. Revenue of $309M (+24% Y/Y) beats by $4M. (PR) Shares -0.4% AH. Comment! [Healthcare, Earnings, Breaking News]
Monday, January 28, 12:10 AM Notable earnings after Monday’s close: BMC, CE, IDTI, ILMN, MSPD, OLN, SANM, STLD, STX, VMW, YHOO, ZION Comment! [Earnings]

1
2
3
4
5
6
...
9
Next Page